In mouse models of breast cancer, blocking IL-1β can inhibit metastatic progression: Holen et al. (2016) demonstrated that using the IL-1 receptor antagonist anakinra in mice markedly reduced the development of breast cancer bone metastases [25]. Here, IL1B is linked to breast cancer.